SCHEMBL29477125

SCHEMBL29477125

CC(C)[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 6/20 0.50
▸ REN P00797 4/20 0.50
▸ CALCRL Q16602 4/20 0.46
▸ KDM4E B2RXH2 1/20 0.42
▸ F2 P00734 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ LTA4H P09960 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ PEPD P12955 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ PTGS1 P23219 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ PTGS2 P35354 1/20 0.42
▸ HRH1 P35367 1/20 0.42
▸ THPO P40225 1/20 0.42
▸ PMP22 Q01453 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ ACE2 Q9BYF1 1/20 0.42
▸ XIAP P98170 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29666870 0.90 ACE (0.52) ACERENCALCRLKDM4EF2
SCHEMBL30792488 0.89 ACE (0.49) ACERENCALCRLKDM4EF2
SCHEMBL30579777 0.89 ACE (0.51) ACERENCALCRL
SCHEMBL30435421 0.87 ACE (0.52) ACERENKDM4EF2LMNA
SCHEMBL9471485 0.87 ACE (0.48) ACERENKDM4EF2LMNA
SCHEMBL10428029 0.87 KEAP1 (0.47) CALCRL
SCHEMBL30435869 0.86 ACE (0.56) ACERENKDM4EF2LMNA
SCHEMBL9705671 0.85 ACE (0.48) ACERENKDM4EF2LMNA
SCHEMBL27953019 0.85 ACE (0.48) ACERENKDM4EF2LMNA
SCHEMBL9705665 0.85 ACE (0.48) ACERENKDM4EF2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240366745-A1 TROPICAL DISEASE VACCINES MODERNATX, INC. (US) 2024-11-07 — — US disclosed
US-20220257746-A1 TROPICAL DISEASE VACCINES MODERNATX, INC. (US) 2022-08-18 — — US disclosed
US-11278611-B2 Zika virus RNA vaccines MODERNATX, INC. (US) 2022-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11278611-B2 Zika virus RNA vaccines RBM3, NSUN3, RBM12 ACE 524/4885REN 3541/4885CALCRL 4053/4885
US-20220257746-A1 TROPICAL DISEASE VACCINES MTREX, DDX5, DIS3 ACE 514/4885REN 2758/4885CALCRL 3353/4885
US-20240366745-A1 TROPICAL DISEASE VACCINES MTREX, DDX5, DIS3 ACE 514/4885REN 2758/4885CALCRL 3353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback